Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 pandemic has brought about a surge in the demand for vaccines worldwide, and Qatar is no exception. The country has been actively working towards vaccinating its population and has been successful in administering vaccines to a significant percentage of its citizens.
Customer preferences: Qatar has a highly diverse population, with a significant number of expatriates residing in the country. The government has made efforts to ensure that all citizens and residents have access to the COVID-19 vaccine, regardless of their nationality or socioeconomic status. As a result, there has been a high demand for vaccines in the country.
Trends in the market: The COVID-19 vaccine market in Qatar has been witnessing a steady growth in recent months. The country has been successful in securing a steady supply of vaccines from various manufacturers, including Pfizer-BioNTech, Moderna, and AstraZeneca. The government has also been actively promoting vaccination and has set up numerous vaccination centers across the country to make the process more accessible for its citizens and residents.
Local special circumstances: Qatar has a relatively small population, which has made it easier for the government to manage the vaccine rollout. The country has also been successful in containing the spread of the virus, which has helped to build public trust in the vaccine. Additionally, the government has been providing free vaccines to all citizens and residents, which has made it more accessible for everyone.
Underlying macroeconomic factors: Qatar has a high-income economy and has been investing heavily in its healthcare sector in recent years. The country has a well-developed healthcare infrastructure and has been able to effectively manage the pandemic. The government has also been providing financial support to businesses and individuals affected by the pandemic, which has helped to mitigate the economic impact of the crisis. Overall, the COVID-19 vaccine market in Qatar is expected to continue growing in the coming months as the government continues to prioritize vaccination and work towards achieving herd immunity.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
